Stoke Therapeutics STOK
NASDAQ STOK
$25.70 +0.02 (+0.08%)
At close: Oct 22, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Ending Cash Balance (2018 - 2019)

Updated

Analysis

Stoke Therapeutics (STOK) Ending Cash Balance (2018 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 6.57 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 3.18 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.03 Bn
10 Stoke Therapeutics 1.60 Bn 434.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 233.25 Mn
Jun 30, 2019 242.89 Mn
Dec 31, 2018 105.60 Mn
Sep 30, 2018 19.42 Mn
Jun 30, 2018 9.60 Mn
API Access

Stoke Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=STOK&period=max&api_key=YOUR_API_KEY